Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01923480 · ClinicalTrials.gov registry record · Phase 4
Dosing Study of Amino Acids in Seriously Ill Patients
A Phase 4 study, sponsored by Baxter Healthcare Corporation.
- Terminated
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT01923480: Clinical Trial Phase 4 study, sponsored by Baxter Healthcare Corporation.
NCT01923480 is a Phase 4 study that was terminated before completion, run by Baxter Healthcare Corporation. The registered enrollment target is 16 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01923480, a Phase 4 study, was terminated before completion, sponsored by Baxter Healthcare Corporation.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the best rate of infusion of amino acids (15% CLINISOL - sulfite-free (Amino Acid) Injection) for nutrition in subjects with with stages II to IVB head and neck cancer.
Interventions
- DRUG 15% CLINISOL - Sulfite-free (Amino Acid) Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-12 |
| Phase | Phase 4 |
Why NCT01923480 stopped before completion
NCT01923480 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which 15% CLINISOL - Sulfite-free (Amino Acid) Injection is the first listed.
NCT01923480 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01923480 about?
NCT01923480 is a clinical study titled "Dosing Study of Amino Acids in Seriously Ill Patients". The purpose of this study is to determine the best rate of infusion of amino acids (15% CLINISOL - sulfite-free (Amino Acid) Injection) for nutrition in subjects with with stages II to IVB head and neck cancer.
What is the current status of trial NCT01923480?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2013-07. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01923480?
The interventions under investigation include: 15% CLINISOL - Sulfite-free (Amino Acid) Injection (DRUG).
Who is sponsoring clinical trial NCT01923480?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01923480's enrollment target sits among peer trials
16 1869th of 2000 higher than 121 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia